The triple test: A cost-effective diagnostic tool

W. A. Schmidt, M. S. Wachtel, M. K. Jones, A. S. Thurmond, P. M. DuBois, Rodney Pommier, John Vetto

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    The triple test (TT), comprising fine-needle aspiration biopsy (FNAB), physical examination, and mammography, is a financially important diagnostic modality in the capitation era. During 31 months, 43 patients in the Multidisciplinary Breast Clinic had 46 temporally congruent physical examinations, mammograms, FNABs, and biopsies with histopathologic results. False-negative rates for physical examination were 4.3%; for mammography, 2.2%; and for FNAB, 2.3%. False-positive rates for physical examination were 15.2%; for mammography, 15.2%; and for FNAB, 0. The TT results presented in this study are essentially identical to those reported elsewhere. The TT is demonstrably more accurate than physical examination or mammography, either alone or in various double combinations. Monetary savings are substantial when FNAB data are used in patient management algorithms based upon the TT. This is the fourth and final article in the CE Update series on cytology. Look for the CE Update exam in this issue.

    Original languageEnglish (US)
    Pages (from-to)715-719
    Number of pages5
    JournalLaboratory Medicine
    Volume25
    Issue number11
    StatePublished - 1994

    Fingerprint

    Biopsy
    Mammography
    Physical Examination
    Fine Needle Biopsy
    Needles
    Costs and Cost Analysis
    Costs
    Cytology
    Cell Biology
    Breast

    ASJC Scopus subject areas

    • Clinical Biochemistry
    • Pathology and Forensic Medicine

    Cite this

    Schmidt, W. A., Wachtel, M. S., Jones, M. K., Thurmond, A. S., DuBois, P. M., Pommier, R., & Vetto, J. (1994). The triple test: A cost-effective diagnostic tool. Laboratory Medicine, 25(11), 715-719.

    The triple test : A cost-effective diagnostic tool. / Schmidt, W. A.; Wachtel, M. S.; Jones, M. K.; Thurmond, A. S.; DuBois, P. M.; Pommier, Rodney; Vetto, John.

    In: Laboratory Medicine, Vol. 25, No. 11, 1994, p. 715-719.

    Research output: Contribution to journalArticle

    Schmidt, WA, Wachtel, MS, Jones, MK, Thurmond, AS, DuBois, PM, Pommier, R & Vetto, J 1994, 'The triple test: A cost-effective diagnostic tool', Laboratory Medicine, vol. 25, no. 11, pp. 715-719.
    Schmidt WA, Wachtel MS, Jones MK, Thurmond AS, DuBois PM, Pommier R et al. The triple test: A cost-effective diagnostic tool. Laboratory Medicine. 1994;25(11):715-719.
    Schmidt, W. A. ; Wachtel, M. S. ; Jones, M. K. ; Thurmond, A. S. ; DuBois, P. M. ; Pommier, Rodney ; Vetto, John. / The triple test : A cost-effective diagnostic tool. In: Laboratory Medicine. 1994 ; Vol. 25, No. 11. pp. 715-719.
    @article{5da24285eacf4e43b31cce2c2c17dad3,
    title = "The triple test: A cost-effective diagnostic tool",
    abstract = "The triple test (TT), comprising fine-needle aspiration biopsy (FNAB), physical examination, and mammography, is a financially important diagnostic modality in the capitation era. During 31 months, 43 patients in the Multidisciplinary Breast Clinic had 46 temporally congruent physical examinations, mammograms, FNABs, and biopsies with histopathologic results. False-negative rates for physical examination were 4.3{\%}; for mammography, 2.2{\%}; and for FNAB, 2.3{\%}. False-positive rates for physical examination were 15.2{\%}; for mammography, 15.2{\%}; and for FNAB, 0. The TT results presented in this study are essentially identical to those reported elsewhere. The TT is demonstrably more accurate than physical examination or mammography, either alone or in various double combinations. Monetary savings are substantial when FNAB data are used in patient management algorithms based upon the TT. This is the fourth and final article in the CE Update series on cytology. Look for the CE Update exam in this issue.",
    author = "Schmidt, {W. A.} and Wachtel, {M. S.} and Jones, {M. K.} and Thurmond, {A. S.} and DuBois, {P. M.} and Rodney Pommier and John Vetto",
    year = "1994",
    language = "English (US)",
    volume = "25",
    pages = "715--719",
    journal = "Laboratory Medicine",
    issn = "0007-5027",
    publisher = "American Society of Clinical Pathologists",
    number = "11",

    }

    TY - JOUR

    T1 - The triple test

    T2 - A cost-effective diagnostic tool

    AU - Schmidt, W. A.

    AU - Wachtel, M. S.

    AU - Jones, M. K.

    AU - Thurmond, A. S.

    AU - DuBois, P. M.

    AU - Pommier, Rodney

    AU - Vetto, John

    PY - 1994

    Y1 - 1994

    N2 - The triple test (TT), comprising fine-needle aspiration biopsy (FNAB), physical examination, and mammography, is a financially important diagnostic modality in the capitation era. During 31 months, 43 patients in the Multidisciplinary Breast Clinic had 46 temporally congruent physical examinations, mammograms, FNABs, and biopsies with histopathologic results. False-negative rates for physical examination were 4.3%; for mammography, 2.2%; and for FNAB, 2.3%. False-positive rates for physical examination were 15.2%; for mammography, 15.2%; and for FNAB, 0. The TT results presented in this study are essentially identical to those reported elsewhere. The TT is demonstrably more accurate than physical examination or mammography, either alone or in various double combinations. Monetary savings are substantial when FNAB data are used in patient management algorithms based upon the TT. This is the fourth and final article in the CE Update series on cytology. Look for the CE Update exam in this issue.

    AB - The triple test (TT), comprising fine-needle aspiration biopsy (FNAB), physical examination, and mammography, is a financially important diagnostic modality in the capitation era. During 31 months, 43 patients in the Multidisciplinary Breast Clinic had 46 temporally congruent physical examinations, mammograms, FNABs, and biopsies with histopathologic results. False-negative rates for physical examination were 4.3%; for mammography, 2.2%; and for FNAB, 2.3%. False-positive rates for physical examination were 15.2%; for mammography, 15.2%; and for FNAB, 0. The TT results presented in this study are essentially identical to those reported elsewhere. The TT is demonstrably more accurate than physical examination or mammography, either alone or in various double combinations. Monetary savings are substantial when FNAB data are used in patient management algorithms based upon the TT. This is the fourth and final article in the CE Update series on cytology. Look for the CE Update exam in this issue.

    UR - http://www.scopus.com/inward/record.url?scp=0028109374&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0028109374&partnerID=8YFLogxK

    M3 - Article

    AN - SCOPUS:0028109374

    VL - 25

    SP - 715

    EP - 719

    JO - Laboratory Medicine

    JF - Laboratory Medicine

    SN - 0007-5027

    IS - 11

    ER -